| Not Yet Recruiting | Information-providing Chatbot NCT07505732 | The Hong Kong Polytechnic University | N/A |
| Recruiting | Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiom NCT07125183 | University of Colorado, Denver | Phase 2 |
| Not Yet Recruiting | Navigation Intervention for Adolescent and Young Adult Cancer Survivors NCT07406087 | Kaiser Permanente | N/A |
| Not Yet Recruiting | my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults NCT07516353 | Dana-Farber Cancer Institute | N/A |
| Not Yet Recruiting | CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors NCT07297160 | Baylor College of Medicine | Phase 1 |
| Not Yet Recruiting | Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas NCT05253131 | University of Alabama at Birmingham | Phase 2 |
| Not Yet Recruiting | Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma NCT07487870 | Andrew Frankart | N/A |
| Not Yet Recruiting | The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors NCT07459283 | FindCure Biosciences (ZhongShan) Co., Ltd. | EARLY_Phase 1 |
| Recruiting | Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivo NCT07402577 | Roswell Park Cancer Institute | — |
| Not Yet Recruiting | BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas NCT07027423 | University Health Network, Toronto | Phase 1 |
| Recruiting | Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) NCT07501026 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Not Yet Recruiting | Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study NCT07389525 | Indiana University | EARLY_Phase 1 |
| Recruiting | Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarco NCT07359911 | University of Miami | N/A |
| Recruiting | EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676 | Essen Biotech | Phase 1 / Phase 2 |
| Not Yet Recruiting | Tumor-Lymph Node Mapping NCT07054944 | University of Rochester | Phase 1 |
| Recruiting | Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refracto NCT07222735 | St. Jude Children's Research Hospital | Phase 1 |
| Not Yet Recruiting | Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients NCT06500715 | Shaare Zedek Medical Center | N/A |
| Recruiting | MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma NCT07359053 | Shanghai 6th People's Hospital | Phase 2 |
| Recruiting | Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial NCT07447050 | University of California, Irvine | Phase 2 |
| Recruiting | Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas NCT07071727 | The Netherlands Cancer Institute | N/A |
| Recruiting | A Study of Pembrolizumab in People With Ultra-Rare Sarcomas NCT07089992 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Not Yet Recruiting | Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing NCT07048184 | NHS Greater Glasgow and Clyde | Phase 2 |
| Recruiting | Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+) NCT07148193 | Technische Universität Dresden | — |
| Recruiting | Pediatric Radiation Therapy Registry NCT07129317 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Recruiting | Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an NCT07192068 | UNICANCER | Phase 2 |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Ra NCT06941194 | Istituto Oncologico Veneto IRCCS | N/A |
| Recruiting | Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma NCT06528769 | Gabriel Tinoco | Phase 2 |
| Recruiting | A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas NCT07014137 | University Health Network, Toronto | Phase 2 |
| Recruiting | 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Fluorescence-Guided Optimization of Sarcoma Margins NCT07134192 | University of Aarhus | N/A |
| Recruiting | IDOV-Immune for Advanced Solid Tumors NCT06910657 | ViroMissile, Inc. | Phase 1 |
| Recruiting | LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients NCT06958107 | Wake Forest University Health Sciences | — |
| Not Yet Recruiting | A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient W NCT07104682 | University of Calgary | EARLY_Phase 1 |
| Recruiting | Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog NCT07118176 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Recruiting | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer NCT06298916 | Lantheus Medical Imaging | Phase 1 / Phase 2 |
| Recruiting | Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety NCT07104955 | Salutare Group Ltd. | N/A |
| Recruiting | WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring) NCT07058064 | Mayo Clinic | N/A |
| Recruiting | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Can NCT06371768 | Duke University | N/A |
| Recruiting | A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma NCT05835154 | Fred Hutchinson Cancer Center | N/A |
| Not Yet Recruiting | Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Su NCT06988007 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Recruiting | PROMIS and Mobility Evaluation in Sarcoma Patients NCT07227961 | University of Calgary | — |
| Not Yet Recruiting | Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcoma NCT06476704 | Institut de cancérologie Strasbourg Europe | Phase 2 |
| Recruiting | Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors NCT06942143 | Guangzhou FineImmune Biotechnology Co., LTD. | Phase 1 |
| Recruiting | SLV-154 Treatment of Metastatic Solid Tumors NCT06771219 | Solve Therapeutics | Phase 1 |
| Recruiting | STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Pa NCT06975293 | STORM Therapeutics LTD | Phase 1 / Phase 2 |
| Recruiting | Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic NCT06805773 | Mount Sinai Hospital, Canada | N/A |
| Recruiting | Lead-212 PSV359 Therapy for Patients With Solid Tumors NCT06710756 | Perspective Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365 | Washington University School of Medicine | — |
| Recruiting | NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma NCT06889766 | Centre Hospitalier Universitaire Vaudois | Phase 1 |
| Not Yet Recruiting | Lipid Mediators & Cancer: Montelukast, SPM, and Almonds NCT06887673 | University of South Florida | EARLY_Phase 1 |
| Terminated | YASU Research Registry: For Young Adults With Cancer NCT06275854 | Young Adult Survivors United | — |
| Active Not Recruiting | CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma NCT06813417 | University of Calgary | EARLY_Phase 1 |
| Not Yet Recruiting | Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk T NCT06526897 | ECOG-ACRIN Cancer Research Group | N/A |
| Recruiting | Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomi NCT06709495 | David S Shulman, MD | Phase 1 / Phase 2 |
| Recruiting | A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172 | Epkin | Phase 1 |
| Recruiting | Biomarkers of Resiliency In Childhood Cancer Surgery NCT06674811 | Mayo Clinic | — |
| Active Not Recruiting | The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognos NCT06751251 | Peking University People's Hospital | — |
| Recruiting | Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial NCT06580002 | University of California, Irvine | Phase 2 |
| Recruiting | Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846 | Fudan University | Phase 2 |
| Recruiting | First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors NCT06644755 | Daiichi Sankyo | Phase 1 |
| Not Yet Recruiting | Physical Activity and Sarcoma, Role and Impact on Outcome NCT06565858 | European Institute of Oncology | — |
| Enrolling By Invitation | Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. NCT06968884 | Region Stockholm | N/A |
| Active Not Recruiting | Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its NCT06850506 | Peking University People's Hospital | — |
| Recruiting | Digital Peer Navigation for Adolescents and Young Adults With Cancer NCT06193369 | University Health Network, Toronto | N/A |
| Recruiting | Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sar NCT06637007 | Shanxi Province Cancer Hospital | Phase 2 |
| Recruiting | Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors NCT06500819 | Crystal Mackall, MD | Phase 1 |
| Completed | WeCanManage. An mHealth Self-management Tool NCT06185738 | University of Illinois at Chicago | N/A |
| Not Yet Recruiting | Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors NCT04889742 | Charite University, Berlin, Germany | Phase 2 |
| Not Yet Recruiting | Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage So NCT06363201 | Catalysis SL | N/A |
| Recruiting | BostonGene and Exigent Genomic INsight Study NCT06272864 | BostonGene | — |
| Recruiting | This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standa NCT06805669 | Mount Sinai Hospital, Canada | N/A |
| Recruiting | A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470 | MacroGenics | Phase 1 |
| Completed | Improved Early Diagnosis in Female Pelvic Cancer With OC Detect NCT06613230 | Region Skane | — |
| Recruiting | Palbociclib and Pembrolizumab in Sarcoma NCT06113809 | John Rieth | Phase 1 |
| Recruiting | FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer NCT05999396 | German Cancer Research Center | Phase 1 |
| Completed | Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From Sarcoma NCT07532668 | Centre Leon Berard | — |
| Recruiting | GRID Therapy for Extremity Soft Tissue Sarcoma NCT06073067 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With NCT06129903 | Memorial Sloan Kettering Cancer Center | N/A |
| Enrolling By Invitation | A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy NCT06113315 | Memorial Sloan Kettering Cancer Center | — |
| Recruiting | Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) NCT06103669 | University of California, Davis | N/A |
| Completed | Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy NCT05707286 | Indiana University | — |
| Recruiting | A Study of CRD3874-SI in People With Solid Tumors NCT06021626 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Novel Applications for Sarcoma Assessment NCT06073314 | The Leeds Teaching Hospitals NHS Trust | — |
| Not Yet Recruiting | Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Soli NCT05361954 | Sorrento Therapeutics, Inc. | Phase 1 |
| Recruiting | A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue NCT05837767 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma NCT06126510 | CNBG-Virogin Biotech (Shanghai) Ltd. | Phase 2 |
| Recruiting | HTL0039732 in Participants With Advanced Solid Tumours NCT05944237 | Cancer Research UK | Phase 1 / Phase 2 |
| Recruiting | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors NCT06171282 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Unknown | Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastati NCT05952128 | Sun Yat-sen University | Phase 2 |
| Recruiting | Clinical Evaluation, Motor Performance and Quality of Life in Patients Affected by Soft Tissue Sarcomas, Under NCT06282237 | Fondazione Policlinico Universitario Campus Bio-Medico | — |
| Active Not Recruiting | A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Sol NCT05812027 | TScan Therapeutics, Inc. | — |
| Recruiting | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors NCT05961111 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Recruiting | ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas NCT05830123 | Hansoh BioMedical R&D Company | Phase 2 |
| Unknown | BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation] NCT04510714 | Instituto do Cancer do Estado de São Paulo | N/A |
| Recruiting | PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) NCT06074692 | Ruijin Hospital | Phase 2 |
| Active Not Recruiting | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid NCT05864144 | Sensei Biotherapeutics, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma NCT05886634 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Phase II Trial of Lung Chemoemobolization NCT05672108 | City of Hope Medical Center | Phase 2 |
| Recruiting | Engineering Immune Organoids to Study Pediatric Cancer NCT05890781 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |
| Recruiting | A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Sol NCT06508307 | GONGCHU Biotechnology Co., Ltd | Phase 1 |
| Terminated | Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers a NCT05819827 | Mayo Clinic | — |
| Recruiting | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Ti NCT05851456 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Terminated | A Study of XmAb23104 in People With Sarcoma NCT05879185 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid T NCT05886075 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Recruiting | Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies NCT05743426 | UNC Lineberger Comprehensive Cancer Center | — |
| Unknown | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (V NCT05708950 | Kineta Inc. | Phase 1 / Phase 2 |
| Unknown | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors NCT05860374 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Active Not Recruiting | START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer NCT05492682 | Valo Therapeutics Oy | Phase 1 |
| Withdrawn | Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures NCT05869994 | Sarcoma Oncology Research Center, LLC | — |
| Completed | A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors NCT05538572 | Prelude Therapeutics | Phase 1 |
| Recruiting | GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 NCT05130255 | Y-mAbs Therapeutics | Phase 1 |
| Completed | Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Can NCT04593277 | Fred Hutchinson Cancer Center | N/A |
| Unknown | Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas NCT05415098 | Ascentage Pharma Group Inc. | Phase 1 |
| Recruiting | Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma NCT04515459 | Institut Claudius Regaud | Phase 2 |
| Recruiting | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069 | Alliance for Clinical Trials in Oncology | — |
| Recruiting | Video Education With Result Dependent dIsclosure NCT05225428 | Dana-Farber Cancer Institute | N/A |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Recruiting | A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Sol NCT05135975 | Nationwide Children's Hospital | Phase 2 |
| Unknown | Study on Clinical Features, Treatment Mode and Survival of Sarcoma NCT05453409 | Henan Cancer Hospital | — |
| Unknown | GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospe NCT06076070 | Regina Elena Cancer Institute | — |
| Enrolling By Invitation | Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients NCT05396118 | Rigshospitalet, Denmark | Phase 2 |
| Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881 | Adela, Inc | — |
| Active Not Recruiting | Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors NCT05121545 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Recruiting | Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan NCT06482957 | Vanderbilt-Ingram Cancer Center | — |
| Unknown | Cryoablation for Advanced Bone and Soft Tissue Tumors NCT05615545 | Henan Cancer Hospital | — |
| Active Not Recruiting | A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced So NCT05238883 | HiFiBiO Therapeutics | Phase 1 |
| Recruiting | Investigating Cognitive Impairment in Young Patients With Cancer Prospectively NCT05840575 | Rigshospitalet, Denmark | — |
| Withdrawn | Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiova NCT05169151 | M.D. Anderson Cancer Center | — |
| Completed | A Study of PRT2527 in Participants With Advanced Solid Tumors NCT05159518 | Prelude Therapeutics | Phase 1 |
| Unknown | Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy NCT05057195 | Blokhin's Russian Cancer Research Center | N/A |
| Unknown | Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary B NCT05057130 | Blokhin's Russian Cancer Research Center | Phase 2 / Phase 3 |
| Completed | Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid NCT05578820 | Gene Surgery LLC | Phase 1 |
| Unknown | Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma NCT05106777 | Sun Yat-sen University | Phase 2 |
| Recruiting | HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced NCT04995003 | Baylor College of Medicine | Phase 1 |
| Recruiting | Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932 | Royal Marsden NHS Foundation Trust | — |
| Recruiting | Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors NCT05187338 | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 / Phase 2 |
| Terminated | Milademetan in Advanced/Metastatic Solid Tumors NCT05012397 | Rain Oncology Inc | Phase 2 |
| Terminated | Study of PF-07263689 in Participants With Selected Advanced Solid Tumors NCT05061537 | Pfizer | Phase 1 |
| Withdrawn | A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas NCT04906876 | Brown University | Phase 2 |
| Completed | A Study of PRT1419 in Patients With Advanced Solid Tumors NCT04837677 | Prelude Therapeutics | Phase 1 |
| Recruiting | Ex VIvo DEtermiNed Cancer Therapy NCT05231655 | Sheffield Teaching Hospitals NHS Foundation Trust | — |
| Unknown | Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sar NCT04960332 | Rigshospitalet, Denmark | N/A |
| Recruiting | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Terminated | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic NCT04644315 | Hoffmann-La Roche | Phase 2 |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Active Not Recruiting | Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors NCT04902872 | Cybrexa Therapeutics | Phase 1 / Phase 2 |
| Active Not Recruiting | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Express NCT04802876 | SOLTI Breast Cancer Research Group | Phase 2 |
| Unknown | Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtyp NCT04741438 | Centre Leon Berard | Phase 3 |
| Recruiting | A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors NCT04673942 | EpicentRx, Inc. | Phase 2 |
| Completed | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid NCT04742959 | TransThera Sciences (Nanjing), Inc. | Phase 1 / Phase 2 |
| Recruiting | Fluorescent Intra-operative Tumor Margin Examination NCT04719156 | Kurt Weiss | Phase 2 |
| Withdrawn | Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advance NCT04464967 | NKGen Biotech, Inc. | Phase 1 / Phase 2 |
| Unknown | Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells NCT04628806 | Charite University, Berlin, Germany | — |
| Suspended | DNX-2440 for Resectable Colorectal Liver Metastasis NCT04714983 | DNAtrix, Inc. | Phase 1 |
| Unknown | Economic Evaluation of Sarcoma Patients Management in France NCT05272358 | Centre Leon Berard | — |
| Unknown | Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazin NCT04893356 | National Cancer Institute, Naples | — |
| Terminated | Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers NCT04072393 | Washington University School of Medicine | N/A |
| Completed | Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment. NCT04802070 | Prof. Franca Fagioli | Phase 1 |
| Unknown | Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices NCT06291662 | Kathleen McGreevy | N/A |
| Withdrawn | Spine and Tumor Screening and Supplementation NCT03660540 | University of Iowa | N/A |
| Unknown | Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Childre NCT05179850 | West China Hospital | — |
| Unknown | Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children NCT04659733 | Yizhuo Zhang | Phase 1 |
| Withdrawn | Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment. NCT03782363 | Italian Sarcoma Group | Phase 1 |
| Recruiting | Enhanced Recovery After Surgery in Extremity Sarcoma NCT04461171 | Joshua Lawrenz | N/A |
| Completed | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients NCT04604158 | Gillian Gresham | N/A |
| Unknown | Augmented Reality (AR): The Future of "Patient Information Leaflets NCT04619030 | NHS Greater Glasgow and Clyde | N/A |
| Active Not Recruiting | Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) NCT04634227 | University of Iowa | EARLY_Phase 1 |
| Withdrawn | Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma NCT03880123 | Matthew Ingham | Phase 1 |
| Completed | Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma? NCT04512495 | Institut Claudius Regaud | N/A |
| Recruiting | GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma NCT04535713 | Sarcoma Oncology Research Center, LLC | Phase 2 |
| Terminated | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors NCT04383210 | Elevation Oncology | Phase 2 |
| Recruiting | Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma NCT04577014 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Terminated | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic NCT04260802 | Ocellaris Pharma, Inc. | Phase 1 / Phase 2 |
| Unknown | Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. NCT04367779 | Centre Leon Berard | — |
| Terminated | Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, NCT04553692 | IGM Biosciences, Inc. | Phase 1 |
| Completed | Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and P NCT04553471 | Washington University School of Medicine | N/A |
| Recruiting | A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous NCT04370587 | ImmVira Pharma Co. Ltd | Phase 1 / Phase 2 |
| Active Not Recruiting | 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma NCT04457258 | Jonsson Comprehensive Cancer Center | EARLY_Phase 1 |
| Recruiting | Using QPOP to Predict Treatment for Sarcomas and Melanomas NCT04986748 | National Cancer Centre, Singapore | — |
| Completed | Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") NCT04474678 | Medical University of Vienna | N/A |
| Withdrawn | Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Tria NCT04190433 | Mayo Clinic | Phase 2 |
| Unknown | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors NCT04556669 | Hebei Senlang Biotechnology Inc., Ltd. | Phase 1 |
| Unknown | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy NCT04517019 | University Hospital Tuebingen | N/A |
| Completed | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S NCT04430842 | Quadriga Biosciences, Inc. | Phase 1 |
| Active Not Recruiting | A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors NCT04511871 | Shanghai PerHum Therapeutics Co., Ltd. | Phase 1 |
| Unknown | Combination Immunotherapy Targeting Sarcomas NCT04433221 | Shenzhen Geno-Immune Medical Institute | Phase 1 / Phase 2 |
| Unknown | A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS NCT04447274 | Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061 | British Columbia Cancer Agency | Phase 2 |
| Recruiting | Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc) NCT03548428 | Centre Antoine Lacassagne | Phase 2 |
| Unknown | Translation and Validation of the German Version of the Toronto Extremity Salvage Score (TESS) and Musculoskel NCT04327908 | Medical University Innsbruck | — |
| Active Not Recruiting | Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® NCT04033081 | CivaTech Oncology | Phase 4 |
| Unknown | A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors NCT05602792 | ImmVira Pharma Co. Ltd | Phase 1 / Phase 2 |
| Recruiting | A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma NCT04332874 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma NCT04076579 | University of Michigan Rogel Cancer Center | Phase 2 |
| Completed | Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas NCT04242238 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Unknown | Chidamide Combined With Toripalimab in Sarcoma NCT04025931 | Sun Yat-sen University | Phase 2 |
| Active Not Recruiting | SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma NCT03778996 | Sarcoma Oncology Research Center, LLC | Phase 2 |
| Completed | Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas NCT04101123 | Martin-Luther-Universität Halle-Wittenberg | — |
| Withdrawn | Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease NCT01125449 | Situs Cancer Research Center | Phase 2 |
| Recruiting | Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers NCT03935893 | Udai Kammula | Phase 2 |
| Unknown | Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory So NCT04107142 | CytoMed Therapeutics Pte Ltd | Phase 1 |
| Unknown | Applying PET/MR in Oncology - a Prospective Project NCT04158414 | Tel-Aviv Sourasky Medical Center | N/A |
| Unknown | MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma NCT04074564 | HRYZ Biotech Co. | EARLY_Phase 1 |
| Recruiting | BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma NCT04072042 | Ruijin Hospital | Phase 2 |
| Recruiting | Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care NCT04300257 | Kantonsspital Winterthur KSW | — |
| Active Not Recruiting | Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma NCT03628209 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Completed | Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Sof NCT04052334 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Unknown | A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma NCT03802071 | Yonsei University | Phase 1 / Phase 2 |
| Recruiting | Registration Study Sarcoma NCT05373810 | Radboud University Medical Center | — |
| Recruiting | The Sarcoma Biology and Outcome Project NCT04758325 | Prof. Dr. Richard F Schlenk | — |
| Unknown | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancie NCT04149691 | Celon Pharma SA | Phase 1 |
| Completed | Progressive Resistance Training for the Improvement of Physical Function NCT04247425 | OHSU Knight Cancer Institute | N/A |
| Recruiting | Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma NCT03896620 | Medical College of Wisconsin | — |
| Completed | A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas NCT03899805 | Dana-Farber Cancer Institute | Phase 2 |
| Unknown | Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma NCT04126993 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors NCT04354064 | Washington University School of Medicine | — |
| Recruiting | Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma NCT03886311 | Sarcoma Oncology Research Center, LLC | Phase 2 |
| Unknown | Assessing Health-related Quality of Life in Sarcoma Patients NCT04071704 | The Netherlands Cancer Institute | — |
| Completed | Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Am NCT03670927 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Completed | A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma NCT03798106 | Yonsei University | Phase 2 |
| Unknown | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958 | SpeciCare | — |
| Completed | TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers NCT03829436 | Tempest Therapeutics | Phase 1 |
| Terminated | PROactive Evaluation of Function to Avoid CardioToxicity NCT03862131 | Washington University School of Medicine | Phase 2 |
| Unknown | Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic NCT03880695 | Peking University People's Hospital | Phase 2 |
| Unknown | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metas NCT03775525 | Genzada Pharmaceuticals USA, Inc. | Phase 1 |
| Completed | Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With Hi NCT03538587 | National Cancer Institute (NCI) | N/A |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |
| Terminated | Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors NCT03604783 | Sumitomo Pharma America, Inc. | Phase 1 |
| Recruiting | GISAR German Interdisciplinary Sarcoma Registry NCT04122872 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | — |
| Terminated | A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma NCT03711279 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Completed | Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC) NCT03800121 | Centre Georges Francois Leclerc | — |
| Completed | Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics] NCT03686566 | University of Texas Southwestern Medical Center | — |
| Unknown | Diagnosis and Definition of Local Involvement of Musculoskeletal Tumors: Assessment of Ultra-high Field MRI Ex NCT03628274 | Assistance Publique Hopitaux De Marseille | N/A |
| Terminated | A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable NCT03520959 | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 3 |
| Completed | T2* MRI Analysis for Sarcoma NCT03658343 | Bryan Allen | — |
| Terminated | A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomi NCT03495921 | Gradalis, Inc. | Phase 3 |
| Active Not Recruiting | Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma NCT03463408 | University of Rochester | EARLY_Phase 1 |
| Terminated | Gemcitabine Plus Ascorbate for Sarcoma in Adults NCT03468075 | Mohammed Milhem, MBBS | Phase 2 |
| Terminated | Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer NCT03630601 | Roswell Park Cancer Institute | N/A |
| Unknown | Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study NCT03539172 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 2 |
| Unknown | Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas NCT03989596 | Maria Sklodowska-Curie National Research Institute of Oncology | Phase 2 |
| Recruiting | Analysis of Circulating Tumor Markers in Blood NCT04025541 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Recruiting | Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With NCT03465592 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 / Phase 2 |
| Completed | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers NCT03454451 | Corvus Pharmaceuticals, Inc. | Phase 1 |
| Completed | Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO NCT03515174 | National Cancer Centre, Singapore | N/A |
| Completed | PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas NCT03076333 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Unknown | CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progr NCT03002805 | CBA Research | Phase 1 |
| Active Not Recruiting | FAZA PET/MRI Sarcoma NCT03418818 | University Health Network, Toronto | N/A |
| Completed | A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma NCT03810976 | Yonsei University | Phase 2 |
| Terminated | REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metast NCT03435640 | Nektar Therapeutics | Phase 1 / Phase 2 |
| Enrolling By Invitation | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology NCT03244020 | Massachusetts General Hospital | Phase 4 |
| Unknown | QUEST: QUality of Life and Experiences of Sarcoma Trajectories NCT03441906 | Radboud University Medical Center | — |
| Active Not Recruiting | A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/o NCT03414229 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | The Safety and Efficacy of Combined Microwave Ablation During Limb-sparing Surgery in High-risk Soft Tissue Sa NCT06802510 | Guangdong Provincial People's Hospital | N/A |
| Active Not Recruiting | Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or O NCT03373097 | Bambino Gesù Hospital and Research Institute | Phase 1 / Phase 2 |
| Unknown | Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas NCT03356782 | Shenzhen Geno-Immune Medical Institute | Phase 1 / Phase 2 |
| Completed | Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma NCT03123276 | Royal Marsden NHS Foundation Trust | Phase 1 / Phase 2 |
| Recruiting | Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method? NCT03261544 | Duke University | — |
| Active Not Recruiting | Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study NCT03144206 | Duke University | Phase 4 |
| Terminated | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physicia NCT02900248 | CureOne | — |
| Completed | Burden and Medical Care of Sarcoma in Germany NCT03521531 | Technische Universität Dresden | — |
| Active Not Recruiting | A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma NCT03282344 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Development of Clinical and Biological Database NCT03449264 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Terminated | Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Tre NCT03240861 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types NCT03012620 | UNICANCER | Phase 2 |
| Unknown | Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma NCT03168061 | NanoCarrier Co., Ltd. | Phase 1 / Phase 2 |
| Completed | PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma NCT03139331 | University of California, San Francisco | Phase 1 |
| Completed | Mobile Self Management and Support for Adolescents and Young Adults With Cancer NCT03130751 | University of California, Los Angeles | N/A |
| Completed | Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy NCT03258892 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Ro NCT03275818 | Grupo Espanol de Investigacion en Sarcomas | Phase 2 |
| Active Not Recruiting | A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/ NCT03069378 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in P NCT03073304 | Vastra Gotaland Region | N/A |
| Completed | Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study NCT03245788 | Stanford University | N/A |
| Unknown | Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Ex NCT03651375 | Maria Sklodowska-Curie National Research Institute of Oncology | Phase 2 |
| Completed | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 NCT03058289 | Intensity Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma NCT03809637 | Yonsei University | Phase 2 |
| Recruiting | Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alt NCT03017573 | Institut Curie | N/A |
| Terminated | Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms T NCT02581384 | Dana-Farber Cancer Institute | Phase 1 / Phase 2 |
| Completed | A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers NCT02643303 | Ludwig Institute for Cancer Research | Phase 1 / Phase 2 |
| Completed | Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma NCT02959164 | Mohammed Milhem | Phase 1 |
| Completed | Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be NCT02888665 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Withdrawn | Adoptive Therapy Using Antigen-Specific CD4 T-Cells NCT02210104 | M.D. Anderson Cancer Center | Phase 1 |
| Withdrawn | HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Soli NCT02557854 | Theodore Laetsch | Phase 1 |
| Terminated | Patient Reported Outcome Measures (PROMs) With Trabectedin NCT03959033 | University of Leeds | — |
| Completed | Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors NCT02988817 | Genmab | Phase 1 / Phase 2 |
| Unknown | Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer NCT02856048 | Assistance Publique - Hôpitaux de Paris | Phase 2 / Phase 3 |
| Recruiting | Establishment of a Prospective Clinical-biological Database NCT04458792 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Completed | Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors NCT02897375 | Emory University | Phase 1 |
| Terminated | Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery NCT02901405 | NHS Greater Glasgow and Clyde | N/A |
| Completed | Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy NCT03964896 | M.D. Anderson Cancer Center | N/A |
| Terminated | Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay NCT02797405 | Centre Leon Berard | N/A |
| Completed | Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma NCT02736565 | Gradalis, Inc. | Phase 1 |
| Active Not Recruiting | Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Co NCT02713269 | M.D. Anderson Cancer Center | Phase 2 |
| Withdrawn | Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metast NCT02839694 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Study of Abemaciclib in Dedifferentiated Liposarcoma NCT02846987 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Terminated | A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or L NCT02576665 | Tocagen Inc. | Phase 1 |
| Completed | Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications NCT02833246 | Memorial Sloan Kettering Cancer Center | N/A |
| Terminated | Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients NCT02575066 | The Netherlands Cancer Institute | Phase 2 |